Cliff Asness's KURA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 2.12 M shares of Kura Oncology, Inc. (KURA) worth $17.27 M, representing 0.01% of the portfolio. First purchased in 2018-Q1, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in KURA, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 1.3 M shares. Largest reduction occurred in Q1 2026, reducing 937,732 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Kura Oncology (KURA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kura Oncology (KURA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -937,732 | Reduce 30.62% | 2.12 M | $8.13 |
| Q4 2025 | +820,020 | Add 36.57% | 3.06 M | $10.39 |
| Q3 2025 | +1.3 M | Add 138.11% | 2.24 M | $8.85 |
| Q2 2025 | +181,343 | Add 23.85% | 941,675 | $5.77 |
| Q1 2025 | +610,604 | Add 407.81% | 760,332 | $6.60 |
| Q4 2024 | +27,213 | Add 22.21% | 149,728 | $8.71 |
| Q3 2024 | +40,860 | Add 50.04% | 122,515 | $19.54 |
| Q2 2024 | +58,422 | Add 251.46% | 81,655 | $20.59 |
| Q1 2024 | -6,757 | Reduce 22.53% | 23,233 | $21.33 |
| Q4 2023 | -80,649 | Reduce 72.89% | 29,990 | $14.38 |
| Q3 2023 | +96,743 | Add 696.19% | 110,639 | $9.12 |
| Q2 2023 | +13,896 | New Buy | 13,896 | $10.58 |
| Q2 2021 | -12,875 | Sold Out | 0 | $0.00 |
| Q1 2021 | -2,630 | Reduce 16.96% | 12,875 | $28.27 |
| Q4 2020 | +15,505 | New Buy | 15,505 | $32.63 |
| Q4 2018 | -18,354 | Sold Out | 0 | $0.00 |
| Q3 2018 | +703 | Add 3.98% | 18,354 | $17.49 |
| Q2 2018 | -10,754 | Reduce 37.86% | 17,651 | $18.19 |
| Q1 2018 | +28,405 | New Buy | 28,405 | $18.76 |
Cliff Asness's Kura Oncology Investment FAQs
Cliff Asness first purchased Kura Oncology, Inc. (KURA) in Q1 2018, acquiring 28,405 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Kura Oncology, Inc. (KURA) for 19 quarters since Q1 2018.
Cliff Asness's largest addition to Kura Oncology, Inc. (KURA) was in Q3 2025, adding 2,242,192 shares worth $19.84 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 2,124,480 shares of Kura Oncology, Inc. (KURA), valued at approximately $17.27 M.
As of the Q1 2026 filing, Kura Oncology, Inc. (KURA) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Kura Oncology, Inc. (KURA) was 3,062,212 shares, as reported at the end of Q4 2025.